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The use of herbal medicine (HM) and its products has significantly increased in the past decade. Type 
2 Diabetes mellitus patients (T2DM) are always rendering herbal medicine as an alternative to the 
current option of treatment to manage their disease. This article is aimed to explore the extent of 
communication process of patients who disclose their HM usage to healthcare providers (HCPs) and 
HCP’s experiences in managing these patients. Purposive sampling method was applied in this 
qualitative study, which involved 28 respondents from four government clinics in Negeri Sembilan, 
Malaysia. A semi-structured interview was developed for the in-depth interview (IDI) and focus group 
interview (FGD). Both IDIs and FGDs were audio-recorded and conducted for approximately (40–60) 
minutes. The contents were transcribed verbatim and thematically analysed. The majority of T2DM 
patients did not reveal their HM usage due to fear of negative feedback, never been inquired by HCP 
and bad experiences after disclosure. Whereas, patients will disclose if they have a good rapport with 
HCPs and HCP asked patients courteously.  However, HCPs reported that they did not discuss HM 
usage with patients due to limited knowledge, patients refuse to admit and time constraint to consult 
patients. Communication between T2DM patients and HCPs during consultation concerning the proper 
use of HM alongside modern medicine needs to be improved. Therefore, a better understanding factor 
of HM usage and its disclosure would make patients more open-minded to discuss and encourage 
HCPs to be attentive to avoid any potential adverse effects in HM usage.  
 




Introduction   
 
A global report on Herbal Supplements and Remedies market shows that the demand for HM in 
healthcare practice continues to grow worldwide and by 2017, the global market for such products is 
expected to be US$104.6 billion. Studies reported that among the most preferred Complementary and 
Alternative medicine (CAM) therapies pursued by chronic patients like diabetics are herbal remedies 
(Boston et al., 2019; Pearson et al., 2018; Jiaranaikajorn et al., 2017; Peltzer et al., 2016). Herbal 
Medicines (HM) have been acknowledged as part of traditional medicines which include herbal plants, 
herbal ingredients and finished herbal products that contain plant parts as active components. Even 
though the HM has been widely used and carries potential risks, most studies revealed that HM usage 
is still hardly discussed between patients with their doctors. 
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According to Liem A. (2019), the national survey conducted by Indonesian Health Ministry reported 
more than 75% of Indonesian people using CAM treatments especially herbal medicines. However, 
the majority of them might not disclose their usage to HCP and presumed it should not be discussed if 
they find their HCP is being skeptical. Another study done by Kretchy et al. (2014) in Ghana reported 
the main reasons of non-disclosure by 70% respondent of CAM user is due to fear of the doctor and 
lack of inquiry by HCP.  Similarly, negative attitudes and belief towards CAM by health practitioners 
make patients reluctant to openly discuss with them. A study in Australia found that there is a 
correlation between knowledge and attitude that is most likely to be negative for health practitioners 
with limited knowledge of CAM (Shorofi & Arbon 2017). 
 
In addition, Toklu (2016) claimed that HM usage is always associated with a few problems, which are 
herb-drug interaction, improper labelling, contamination, unknown composition, lack of 
standardisation for active components dosage and inappropriate dose.  Although herbal products are 
thought to be harmless amongst patients, there may be side effects and potentials to cause drug 
interactions (Tuluney et al. 2015); hence, the study stated that adverse drug effects, toxicity, and 
treatment failure were more likely to occur when herbal products were consumed with conventional 
medicines. Moreover, with intensive usage but limited disclosure of HM, patients may expose 
themselves to risks, for instance, making uninformed decisions regarding other treatments, involving 
drug interactions, misdiagnosis and mismanagement of their diseases (Liem, A., 2019). As a 
consequence, serious complications can occur and affect the healing period of their illness.  
 
The growing use of herbs requires appropriate rules and regulations under the Medical Act for safety 
reasons. HCPs should be aware of their patient’s HM usage and advise them of the potential unwanted 
side effects in medicine-drug interaction. A better understanding of HM usage will help patients to be 
more open-minded to discuss with HCPs and allow HCP to be attentive and patient-centred, 
particularly during counselling sessions with regard to proper usage of herbal remedies. Therefore, this 
study was intended to explore the communication process and determine the extent that patients 






The study sample consisted of T2DM patients and HCPs selected from four government clinics in 
Negeri Sembilan, namely Seremban Health Clinic, Port Dickson Health Clinic, Kuala Pilah Health 
Clinic, and Bahau Health Clinic. Selection of clinics was based on the highest number of diabetes 
patients registered at the clinics.   
Data Collection 
 
For interview process, the researcher used primarily open-ended questions to extract full information 
from the informants and applied the probing techniques. The interview took 40-60 minutes for the 
interviewer to complete, while a research assistant was tasked with taking notes. However, informants 
were assembled as a group for the FGD session. The discussion was driven by a semi-structured 
questionnaire consisting of questions on the use of herbal medicine and their patient management 
experience. One researcher acted as a moderator and the other research assistant as a note taker. 
Thematic saturation has been reached when the researcher found no more new themes emerged from 
the data.  
Both IDIs and FGDs were conducted in a closed room. Samples were selected via purposive sampling 
and according to their eligibility, which included: Malaysian who were between 18 years and above, 
diagnosed with diabetes for more than three years, and used HM in managing diabetes for 12 months 
and above. However, the participating HCP group in this study was selected from medical staff 
working in the Out Patients Department. An appointment for IDI and FGD sessions was scheduled 
when the participation was confirmed.  







Both IDIs and FGDs were audio-recorded and the contents were transcribed verbatim. However, field 
notes were taken by research assistant to interpret the data especially for non-verbal communication. 
The data were thematically analysed and were sorted into various themes and subthemes. The analysis 
started with listening to the audio-recording and reading each transcript line by line to identify and 
extract data to initial codes relevant to the study objectives. Then, similar codes were applied to all 
transcripts and the themes or subthemes were identified. The various themes were identified from 
literature. New themes also arose spontaneously from informants during the interviews. The thematic 
analysis was done after peer checking and before the final analysis was conducted. All the data were 




Ethical approval was obtained from the Medical Research Ethics Committee (MREC), Ministry of 
Health with an approval number (NMRR ID: 17-953-35849), whereas the approval to conduct this 
study was granted at the state level and heads of departments from respective clinics. Written consent 
was obtained from respondents prior to the audio-recording interviews for data collection and they 






Summary of Informants 
 
A total of 47 respondents were recruited for this study, and they were aged from 30 to 60 years. The 
multiracial groups had 28 patients, which comprised three main ethnicities in Malaysia: Malays, 
Chinese and Indians. All patients were diagnosed with DM and have on-going treatment with 
respective government health clinics in Negeri Sembilan for more than three years. However, 19 
respondents who were recruited from the HCP group consisted of Diabetes Nurse Educator, Medical 
Officer, Family Medicine Specialist, Staff Nurse and Medical Assistant.  
 
 
Factors of Non-disclosure of HM Usage 
  
Respondents were asked to describe potential factors that enabled them to disclose their HM usage as 
the primary choice of treatment for diabetes. Based on the study findings, the most prompted reason 
was fear of negative feedback from HCPs. The majority of patients informed that they feared if the 
HCPs will scold them and believed that the HCPs will also disapprove their self-practice of HM usage. 
Besides, patients reported that the HCPs never inquired them regarding their HM usage during 
consultation. Therefore, they were not really keen to disclose. They prefer to keep it as a secret until 
they were asked personally. However, some patients revealed that they did tell the HCPs about HM 
usage but were reluctant to share it anymore because they had bad experience after disclosure.  
 
Fear of negative feedback 
  
Half of the patients never thought of disclosing their HM usage to HCPs because they fear of getting 
negative feedback from them. Patients were afraid of being scolded if they informed about their HM 
usage to HCPs and perceived that most HCPs did not believe in HM, and thus they will be rejected. 
Therefore, most patients presumed that it was unnecessary to share about the HM usage, unless the 
HCP asked them nicely.  
 
“But later if I asked the doctor, I was afraid if the doctor would be angry, take this 
medicine, but I still want to take traditional meds too. That’s why I’m afraid to ask, 
later I get scolded” (PT6, Female, 66, Chinese) 






“No lah, I’m afraid…If I tell him, he will scold me. If they ask me to fill up a form 
or ask me if I have taking any herbal meds, I will say no”. (PT17, Female, 51, 
Indian) 
 
“In my opinion, mostly doctors they didn’t believe in traditional meds, that’s why I 
didn’t tell…” (PT23, Male, 69, Malay) 
Never been inquired by HCP 
 
In some cases, patients did not reveal their HM usage because most of the time HCP never questioned 
them, and as usual it was not part of the patient-HCP discussion. Besides, a patient once reported that 
the HCP will provide conventional medicines only as a routine during consultation, together with 
common diabetes management advice.  
 
“Because the doctor never asks me, he just add medicine, and advise me to control 
eating, that’s it lah. Never think of it (to tell doctor) because doctor never ask, I 
also never think about it…”(PT3, Female, 66, Indian) 
 
“No, if the doctor asks me, maybe I will tell him. Last time the nurse did ask me 
(about taking herbs), if she didn’t ask, I won’t tell her also…”(PT23, Male, 69, 
Malay) 
 
“Not yet. Never. They never ask, so I keep silent lah” (laughing). (PT12, Male, 64, 
Malay) 
 
Bad experiences after disclosure 
 
Patients reported they encountered unpleasant experiences when they informed about their 
HM usage. Once a patient was scolded and the HCP was being sarcastic about 
complementing both medicines; hence, patient feels demotivated to reveal their HM usage 
again in the future. 
 
“I don’t like any doctor. I got scolded. I always getting scold by them”. (PT17, 
Female, 51, Indian) 
 
“Err, I told one of private doctors once, I said.. Normally, I take that Murungai 
leaves, traditional thing, he said if you took traditional herbs then why you come 
for this western medicine? He asked me like that. So, starting from that time, I 
didn’t tell the doctor anything”. (PT2, Female, 63, Indian) 
 
 
Factors of Disclosure of Herbal Medicine Usage 
 
Despite the bad experience, several informants voluntarily disclosed their herbal intake due to a good 
relationship with the HCPs. They want to get professional advice and usually, the HCPs will give 
positive feedback by encouraging them to proceed together with CM if their HbA1c result was good. 
Besides, some patients informed that they disclosed when the HCPs initiated a conversation and 
enquired nicely regarding the HM usage.  Therefore, it is crucial for HCPs to acknowledge HM usage 
by learning how to discuss it with their patients. The HCPs should be “open-minded” so that in the 
future patients will be more confident to share.  
 
Patients having a good rapport with HCP 
 
HCPs mentioned that some patients openly informed about their HM usage due to a good relationship 
with the HCPs and they need professional advice on this matter. Similarly, some patients stated that 





they felt comfortable and received positive feedback (advice), especially if their HbA1c result was 
good.  However, the HCP would also advise them not to forget to take CM. 
 
“…Sometimes when patients arrived at the clinic, if she closes with us, she will 
story, Haaa… I took this and that, and then we can ask more. If they are close with 
us, they will tell stories”. (HCP 15, Female, 49, Malay) 
 
“Indeed yes, there are patients who consume HM and admit to me and their HbA1c 
result is very good. For example, I got one Indian patient who confessed to me she 
took ginger every day. She blends that and boiled it from one cup until becomes the 
half cup, then she drinks it every morning without a miss. Aaa…she used to take 
Metformin 850mg BD before, but now only 250 mg OD…and her HbA1c never 
more than 6.2”. (HCP 2, Female, 34, Malay) 
 
“…No lah, but mostly who admit it will ask me, doctor, is this medicine safe to 
consume?”. (HCP 10, Male, 32, Malay) 
 
“I show them lah but they said if you want to take okay no problem lah but make 
sure you take your medication. They said you don’t forget to take your medicine”. 
(PT25, Male, 61, Indian) 
 
HCP asked patients courteously  
 
Nevertheless, there were cases, whereby the HCPs need to initiate a better approach to make the 
patients disclose their HM usage. Usually, HCPs will ask when there are changes in the diabetes 
condition. As modern medical practitioners, HCPs justified that even if they know patients are taking 
HM, they are prohibited from suggesting any other alternative medicines. Therefore, they start a 
conversation by sharing a story and asked patients courteously to share their HM usage. 
 
“For example, I will ask ermm…have you take any other meds?  If she said no, I 
will tell her, it’s okey. If you have taken, just tell me…I won’t scold you, I’m just 
asking, if you have taken any, I would like to know. Aaaa, if I told like that, then 
she will voluntarily admit it “. (HCP 3, Female, 35, Malay) 
 
“Usually, if before this I notice any changes and become worse, I will ask them, 
and they will story to me what exactly happened”. (HCP 13, Female, 49, Malay) 
 
“I used to share a story, like me…honestly, ermm, from my experience ermm… we 
are not allowed actually, at the first place to propose or suggest any alternative 
medicine even though we know it works for certain people. But the way we ask is, I 
just want to share a story, it’s okey…you can come and show me. I’ll try to tell you 
to explain what it is”. (HCP 1, Male, 38, Indian) 
 
 
HCP’s experiences in dealing with patients 
 
Most HCPs stated that they could not give proper advice as they did not have sufficient knowledge 
about HM, which hindered them from encouraging patients on the usage. They claimed that the 
limitation made patients refuse to admit, and thus, there was no need to discuss further on that matter. 
In general, the majority of HCPs confessed that they did not have enough time to consult patients who 
wanted to disclose their HM usage. Therefore, it was observed that the distinct attitudes between 










Unable to advise patient due to limited knowledge 
 
HCPs reported they were unable to give proper advice to patients, except to ask them to stop because 
they know that their knowledge about HM was limited and beyond their field. Moreover, they are not 
well-trained to give any advice and perceived that HM lacks scientific evidence of efficacy. Even 
though they admitted they were worried, but they never asked about HM usage in diabetes self-
management. 
 
“Honestly, when I see patient, I seldom ask them about herbal medicine. And if I 
did ask, I won’t go into detail because we don’t know what to ask and we know 
nothing about that herbs. So, usually I will advise them to stop taking HM, but take 
conventional meds only because herbs have no research or evidence based on their 
efficacy or any side effects. What makes me worry is kidney failure, liver damage 
could happen to them. Aaa, but I never ask them further about consuming that 
(HM)”. (HCP 9, Male, 28, Malay) 
 
“As we know, our knowledge about HM truly limited and we don’t know what are 
the ingredients. Sometimes they bought from outside, they put something harmful 
like steroid and so on. So, it will be more dangerous. I think I have been quite strict 
about that and tell them to stop immediately”. (HCP 11, Female, 30, Malay) 
 
“Because you have patient who just come and then they ask us what is this, is it 
safe to take? But there are 100 billion things out there you know and we are not 
trained to, to actually give them some advice”.(HCP 1, Male, 38, Indian) 
 
“I will say, okey I don’t have any knowledge on that part to say it is wrong…”. 
(HCP 7, Female, 36, Malay) 
 
Patients refuse to admit 
 
Majority of HCPs commented that most patients will deny or lie about HM usage after being asked 
because patients perceived HCPs were being sceptical and not interested. Patients were worried and 
aware they were at risk to get adverse effects. 
 
“No…Most of them will deny “. (HCP 4, Female, 48, Indian) 
“Aaa so sometimes yes. Patients in denial it’s just that ermm…the way we ask must 
capture with what they are taking actually”. (HCP 3, Female, 35, Malay) 
“Haa…some people they think conventional meds is harmful. That’s why they want 
to try herbal medicine. But when we asked… they still don’t want to admit lah…”. 
(HCP 9, Male, 28, Malay)  
Time constraint to consult patients 
 
HCPs claimed that time constraint is the main reason why they did not consult patients in detail 
regarding the HM usage. The reason for HCPs could not commit further discussion on HM usage was 
a greater number of patients waiting for consultation. 
 
“So, alternative medication is actually very time consuming for me personally 
because of the restrain in time, it’s very hard to go in-depth with that. Ermm… a 
lot of patients do talk to me but I can’t go much in it”.(HCP 5, Female, 42, Indian). 
 
“The sharing of taking alternative medication for me personally is very limited 
because of time factor. You want to talk more but you know at the same time you 
need to key-in all everything”. (HCP 4, Female, 48, Indian) 





“Honestly, I’m hardly ask my patient whether they have taken traditional 
medication or not, and usually when we see so many patients, we want to be fast 





The present study demonstrated the communication process between patients and HCPs to 
comprehend to which extent patients’ disclosure about the use of HM to HCPs and HCP’s experiences 
in treating diabetes patients using HM. The majority of patients showed poor communication towards 
disclosing their HM usage to their HCPs due to fear of negative feedback. This was explained by 
several studies which mentioned the fear of doctor-rejection and disagreement on CAM usage as the 
major reason of non-disclosure (Ibrahim et al., 2018; Jou & Johnson 2016; Hwang et al., 2015; 
Kretchy et al., 2014). Moreover, this was consistent with a study done by Liem A. (2019), which cited 
patients unlikely to disclose their self-care practices including CAM use because they concern about 
doctor’s feedback. Similarly, HCP’s negative or judgmental remarks made patients reluctant to share 
their HM usage (Mekuria et al., 2018 and Avila et al., 2020).  
 
In addition, patients in this study underlined the manner in which HCP never asked them regarding 
HM usage during the consultation. HCPs will mostly continue to prescribe conventional medicine and 
giving some advice regarding diabetes management without asking further unless if they noticed 
extraordinary results in HbA1c. A similar finding was reported by a previous study conducted by Jou 
& Johnson (2016) in the United States which found the most cited reason for non-disclosure was the 
doctor did not inquire about the use of CAM. It is uncommon to discuss with a patient about CAM 
unless the patient initiates the conversation (Shelley et al., 2009). Another study also reported that 
almost all physicians did not ask patients about their HM usage history (Memon et al., 2017; Zhang et 
al., 2012). Meanwhile, Ibrahim et al. (2018) also quoted comparable findings in which all respondents 
reported their doctors never asked regarding any treatment with CAM and very few of them disclose 
their CAM usage to the doctors. Therefore, it is not surprising healthcare professionals are not always 
aware of CAM used by patients. 
 
On the other hand, several informants in the current study revealed that they had a bad personal 
experience after they confessed about their HM usage because the HCPs scolded them and were being 
sarcastic. It made them feel sad, scared and demotivated simultaneously. This might explain why 
patients refuse to disclose the HM usage alongside taking their conventional medicine. In addition, this 
finding is comparable to other study which reported that their respondent received a negative reaction 
from the healthcare professional upon disclosure (Liem A. 2019; Jou & Johnson 2016). A negative or 
passive response should be avoided by HCPs while treating the patient as it may result in a decreased 
patient’s health status and bear a higher cost in the healthcare system due to mistreatment to the patient 
(Chang et al., 2011). 
 
Meanwhile, another key finding obtained from this study was that patients disclose their HM usage 
due to good relation with their HCPs and feel comfortable to share. Developing virtuous relationships 
will make patients feel secure to share further details about their health and care expectations (Hamed 
Abdalla et al., 2020). Patients usually will receive positive feedbacks, especially if they get good 
HbA1c results. This finding was in line with another study which found that patients admitted their 
use of HM after observed their HbA1c results was improved (Memon et al., 2017). Moreover, this 
study revealed that patients disclose to their HCPs because they want to get professional advice with 
hope HCPs will support them to continue taking HM. Most HCPs who have a positive attitude towards 
HM will allow them to take HM as complementary to CM. They believed that the efficacy of HM will 
help patients to manage their diabetes better than before.  
Besides, the present study revealed that a few patients disclosed their HM usage, especially after being 
politely asked or persuaded. The HCP’s attitude towards HM also affected the patient’s willingness to 
openly disclose their HM usage. This was parallel with a study done by Bello et al. (2012) which 
indicated patients were willing to answer questions and disclose when they were concerned about 





CAM adverse side effects, HCPs showed good attitudes towards them and asked in a good manner. A 
friendly approach by HCPs could help patients to boost their confidence in revealing their HM usage 
and make it easier for HCPs to share advice on potential adverse effects of HM such as palpitations, 
abdominal pain and hot flushing after taking HM for diabetes treatment (Soner et al., 2013).  
In regard to HCP’s experience in dealing with diabetic patients, the majority of HCPs in this study 
claimed they were unable to advise patients properly unless they asked the patients to stop taking HM 
due to inadequate of knowledge HM and it was beyond their field. Moreover, it was difficult to make 
an informed judgment for the patients as it could contradict the evidence-based principle of the 
medical stream which can affect their professionalism. This is consistent with a study done by Babar et 
al. (2012) who reported similar findings where HCP who lacking of CAM knowledge are unable to 
counsel patients on CAM usage. Memon et al. (2017) and Zhang et al. (2012) also indicate that 
patients did not discuss CAM with their doctor because they perceived the doctor was ignorant and 
having insufficient knowledge. This finding clearly showed that doctor needs to be knowledgeable as 
it is essential to be a well-rounded professional to properly advise patients. 
 
Nonetheless, HCPs commented that most patients would deny even though sometimes they did ask 
their patients regarding HM usage. Meanwhile, this study revealed that patients will not initiate the 
topic in the discussion if they notice HCPs are being skeptical and not interested.  Besides, the 
correlation analysis of Ibrahim et al. (2018) study revealed that an inverse relation which patients who 
have demonstrated a favourable attitude towards CAM were found to rarely disclose to their HCPs. 
This may imply on the risk of inaccurate diagnosis and serious adverse effects. An open discussion 
should be held to avoid miscommunication between patients and HCPs. Moreover, patients believed 
that it was unnecessary to ask HCPs as they may not have good knowledge about HM usage. A study 
by Arcury et al. (2012) and Hasan et al. (2009) also reported the same findings, whereby the majority 
of CAM users denied the necessity of asking doctors and did not accept that doctors have good CAM-
related knowledge.  
Furthermore, this study highlighted on HCPs never assessed the use of HM due to time constraints. 
HM usage was rarely discussed by both groups of patients and HCPs.  This finding was similar to a 
study done by Kamel et al. (2017), whereby the majority of patients reported that they never discussed 
their HM utilisation with their physicians. Another study done by Ibrahim et al. (2018) also reported 
the same findings, in which the majority of respondents (82.8%) agreed that doctors did not have 
enough time to discuss CAM. Similarly, another consensus was found in several studies in which most 
patients agreed that insufficient consultation time with their HCP was a barrier to disclose their CAM 
usage and therefore, they never thought to bring up for discussion (Jou & Johnson 2016; Chiba et al., 





In conclusion, this study has identified patient’s concerns towards fear of negative feedback, never 
been inquired by HCP and bad experience after disclosure as a major reasons of HM non-disclosure. 
On the other hand, patients decided to disclose their use of HM due to a good rapport with HCP and 
were courteously persuaded. These findings might help HCP to improve their communication skills 
and practice more during consultation time. Besides that, understanding patient usage for both types of 
medicine may be valuable to minimize the risks of HM-CM potential drug interaction. Therefore, 
patient’s behaviour and communication skills concerning HM consumption should be highlighted 
through the health education programme. In a nutshell, understanding views from both groups is 
crucial to develop an opportunity for patients to have a better self-care in diabetes management and for 
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